Pakistan flora is enriched with potent bioactive compounds that must be explored while Alzheimer's disease (AD) poses a global challenge driven by neurochemical imbalances. Acetylcholinesterase (AChE) inhibitors traditionally alleviate symptoms, but addressing the root cause remains elusive. This gap has led to the exploration of herbal sources for interventions. In this context, we analyzed fifty 50 medicinal plants for their phytochemical composition and antioxidant and acetylcholinesterase inhibition activities. AChE activity was measured using Ellman’s method. Santalum album exhibited significant AChE inhibition (86.2%), surpassing galantamine hydrobromide (81.8%). Promising inhibition was also seen in Bombax ceiba (77.8%), Acacia karoo (52.9%), and Phaseolus lunatus (50.1%). Detailed analysis revealed Santalum album's abundance in terpenoids, flavonoids, tannins, and phenolics, potentially correlating with its antioxidant and AChE inhibitory effects. Acacia karoo demonstrated elevated levels of total alkaloids, antioxidants, terpenoids, and tannins. Both Acacia karoo and Santalum album show promise for AD intervention due to their AChE inhibitory activities and unique phytochemical attributes, warranting further exploration, particularly for Acacia karoo's novel potential in AChE inhibition, to advance targeted AD therapeutics utilizing natural resources. This study contributes to the search for effective AD strategies from nature's pharmacological resources.